A longitudinal 2-year follow-up of quality of life in women referred for colposcopy after an abnormal cervical smear
article
OA: closed
CC0
AI-generated summary
Women referred for colposcopy after an abnormal cervical smear experienced long-lasting negative effects on mental health but not physical health, with depression influencing perceived quality of life.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo evaluate the long-term impact on quality of life (QoL) in women referred for colposcopy after an abnormal cervical smear.Study designOne hundred consecutive women referred for colposcopy for the first time subsequent to receiving notification of an abnormal cervical smear. Women in the study group completed the Swedish Health Survey Short Form-36 (SF-36), the State/Trait Anxiety Inventory (STAI, Form Y), and the Montgomery Asberg Depression Rating Scale, Self-rate (MADRS-S). The women had follow-up visits at 6 months and 2 years.ResultsThe baseline mean for the mental component summary score and for all mental subscale scores on the SF-36 were statistically significantly lower than Swedish normative data for women. At the end of 2 years, the mental component summary scale and vitality were still significantly lower than such data. There were no differences in QoL between women having had treatment with Large Loop Excision of the Transformation Zone (LLETZ) compared to those who did not. When studied separately, non-depressed women felt no impact on QoL whereas women with higher depression scores judged their mental health QoL worse.ConclusionsWomen experienced long-lasting negative effects on their mental health, but not on their physical health after referral for colposcopy. LLETZ had no measurable influence on QoL at any of the visits. This indicates that it is not the severity of the lesions or the treatment itself that affects women but the fact of having had an abnormal cervical smear identified. Depressive mood may be a major variable for the perception of low QoL.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (35)
- Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial via openalex
- doi:10.1136/bmj.324.7351.1417 via openalex
- doi:10.1007/s00404-005-0118-7 via openalex
- doi:10.1016/s0895-4356(98)00101-2 via openalex
- doi:10.1016/s0140-6736(99)04101-x via openalex
- doi:10.1006/pmed.1995.1096 via openalex
- doi:10.1016/j.ygyno.2005.01.010 via openalex
- W614531583 via openalex
- W1493773294 via openalex
- W1607171655 via openalex
- W1773220658 via openalex
- W1855775495 via openalex
- doi:10.1136/bmj.305.6846.160 via openalex
- doi:10.1136/bmj.299.6698.527 via openalex
- doi:10.1111/j.1471-0528.2006.01161.x via openalex
- doi:10.1515/jpem.2001.14.s1.669 via openalex
- doi:10.1111/j.1471-0528.2001.00121.x via openalex
- W4285719527 via openalex
- W6637949247 via openalex
- W6638869112 via openalex
- W6644811673 via openalex
- W6658304812 via openalex
- doi:10.1111/j.1525-1438.2006.00599.x via openalex
- doi:10.1016/s0306-5456(00)00121-2 via openalex
- doi:10.1016/j.ajog.2005.02.131 via openalex
- doi:10.1016/s0895-4356(98)00102-4 via openalex
- doi:10.1200/jco.1994.12.3.608 via openalex
- doi:10.1111/j.1651-2227.1985.tb10032.x via openalex
- doi:10.1111/j.1600-0447.1994.tb01480.x via openalex
- doi:10.1136/ijgc-00009577-200605000-00022 via openalex
- doi:10.1111/j.1471-0528.2002.99023.x via openalex
- doi:10.1097/00005650-199303000-00006 via openalex
- doi:10.1016/0277-9536(95)00125-q via openalex
- doi:10.1097/01.aog.0000140684.37428.48 via openalex
- doi:10.1111/j.1471-0528.2007.01609.x via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:18:49.075943+00:00
License: CC0
· commercial use OK